Skip to content
Epiontis ID Logo
  • Technology
  • Applications
  • Resources
  • Contact
  • Home
  • Technology
  • Applications
  • Resources
  • Contact
Filters

Epiontis ID: Use Cases Across Diverse Therapeutic Areas

Reza Sedaghat2023-08-28T11:24:59-04:00Resources|

Read More

Exploring Biomarkers to Predict the Response to Immunotherapy-Based Combination Treatment in Hepatocellular Carcinoma Using Epiontis ID™

Reza Sedaghat2022-10-06T10:33:50-04:00Resources|

Read More

Effects on CD3, Treg, and TH17 Cell Numbers in Skin Biopsies After 16-Week Mirikizumab Treatment, Evaluated by an Epigenetic Assay

Carlos Bonilla2022-08-08T17:01:14-04:00Resources|

Read More

Etrolizumab Treatment Increases Blood Levels of CD3, Treg and Th17 Cells Measured Through Epigenetic Activation of CD3, FOXP3 and IL-17 Loci

Carlos Bonilla2022-08-08T17:06:12-04:00Resources|

Read More

Biological Impact of Iberdomide in Patients With Active Systemic Lupus Erythematosus

Carlos Bonilla2022-08-19T16:19:48-04:00Resources|

Read More

Regulatory T-Cells and Associated Pathways in Metastatic Renal Cell Carcinoma (mRCC) Patients Undergoing DC-Vaccination and Cytokine-Therapy

Carlos Bonilla2022-08-08T17:11:33-04:00Resources|

Read More
  • Home
  • Technology
  • Applications
  • Resources
  • Contact
© Precision Medicine Group, LLC.
All Rights Reserved.
Privacy Policy GDPR